Hospital Clinico de Santiago, Spain Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2013
NCT02204332
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Hospital Clinico de Santiago

Active Ingredients

Drugs in Phase 2 Trials (1)

cabazitaxel (jevtana kit) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1